Sort
15,842 grants matching “pancreatic cancer”
Molecular Imaging Methods for the Detection of Pancreatic Ductal Adenocarcinoma
$917,296Andrei Iagaru · Stanford University · U01 · FY2019 · CA
New Ways of Targeting K-Ras
$915,943Frank Patrick McCormick · University Of California, San Francisco · R35 · FY2019 · CA
Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma
$915,566Randall Brand · University Of Pittsburgh At Pittsburgh · U01 · FY2023 · CA
Development of a safer stem cell-based diabetes therapy via suicide gene-mediated ablation of proliferative cells
$915,136Dena E Cohen · Regenerative Medical Solutions, Inc. · R44 · FY2025 · DK
Immunotherapy for Malignant Mesothelioma
$914,751Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Biology and Function of Exosomes in Cancer
$914,441Raghu Kalluri · University Of Tx Md Anderson Can Ctr · R35 · FY2024 · CA
Tissue factor-dependent coagulation in thrombosis and immune responses
$914,340Nigel Mackman · Univ Of North Carolina Chapel Hill · R35 · FY2024 · HL
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells
$910,513Ettore Appella · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Consultation and Collaboration
$910,442Barry Graubard · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA
Defining the Role of Tumor-Neutral Crosstalk in head and Neck Cancer Progression and Treatment Resistance
$910,254Moran Amit · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA
Human Monoclonal Antibodies Against Cancer
$909,717Dimiter S Dimitrov · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Targeting undruggable RAS for cancer treatment
$909,182Channing J Der · Univ Of North Carolina Chapel Hill · R35 · FY2018 · CA
Computational Tools For Bioinformatics And Genome Analysis
$908,951John I Powell · Center For Information Technology · ZIA · FY2012 · CT
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
$906,883Martin W Brechbiel · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA
Studying factors controlling cancer progression and immune recognition in mouse models
$906,300Tyler E Jacks · Massachusetts Institute Of Technology · R35 · FY2024 · CA
Development of Monoclonal Antibodies to Treat Pancreatic Cancer
$905,989Sripathi M Sureban · Coare Biotechnology, Inc. · R44 · FY2016 · CA
Internet-Delivered Pain Self-Management to Reduce Pain and Interference in Chronic Pancreatitis
$905,631Tonya M Palermo · Seattle Children'S Hospital · R01 · FY2023 · DK
Novel approaches to improve prediction of cancer-associated thrombosis
$905,594Keith R. McCrae · Cleveland Clinic Lerner Com-Cwru · U01 · FY2018 · HL
Using ex vivo, in vivo models and patient mutations to interrogate pancreatic exocrine-endocrine cross talk
$904,104Rohit N. Kulkarni · Joslin Diabetes Center · U01 · FY2024 · DK
A Phase 2, Single-Arm Study of the CXCR1/2 Inhibitor SX-682 Plus Enzalutamide in Men with Abiraterone-Resistant Metastatic Castration Resistant Prostate Cancer (mCRPC)
$903,852Aaron D Schuler · Syntrix Biosystems, Inc. · R44 · FY2025 · CA
Molecular Diagnostics Core Laboratory
$903,497Liqiang Xi · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Cancer Immunotherapy Clinical Trials
$902,872Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
$902,819Randall Brand · University Of Pittsburgh At Pittsburgh · U01 · FY2016 · CA
Targeting undruggable RAS for cancer treatment
$902,485Channing J Der · Univ Of North Carolina Chapel Hill · R35 · FY2023 · CA
SPORE in Pancreatic Cancer
$902,341University Of Alabama At Birmingham · P20 · FY2004 · CA